TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today ...

The oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 revealed a manageable safety profile in relapsed ...

Organ Preservation Market Organ Preservation Market grows with rising transplants, advanced perfusion tech, and demand for solutions that b ...

Tough times don’t last, but tough men do. And it is safe to say that Ben Askren is living proof The post ‘Healing’ Ben Askren Readmitted To Hospital After Double Lung Transplant: “Not All Sunshine And ...